GB Sciences, Inc. (GBLX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0003 (-60.00%)
Aug 18, 2025, 12:22 PM EDT

GB Sciences Statistics

Total Valuation

GB Sciences has a market cap or net worth of 40,707. The enterprise value is 2.03 million.

Market Cap40,707
Enterprise Value 2.03M

Important Dates

The last earnings date was Tuesday, August 12, 2025.

Earnings Date Aug 12, 2025
Ex-Dividend Date n/a

Share Statistics

GB Sciences has 407.07 million shares outstanding. The number of shares has increased by 4.24% in one year.

Current Share Class 407.07M
Shares Outstanding 407.07M
Shares Change (YoY) +4.24%
Shares Change (QoQ) n/a
Owned by Insiders (%) 1.67%
Owned by Institutions (%) n/a
Float 400.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.42
PB Ratio -0.01
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.93
EV / Sales 20.90
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.02

Current Ratio 0.02
Quick Ratio 0.00
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -4.36

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -438.99%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 15.94%
Revenue Per Employee 48,618
Profits Per Employee -527,753
Employee Count2
Asset Turnover 0.80
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -92.81% in the last 52 weeks. The beta is 9.86, so GB Sciences's price volatility has been higher than the market average.

Beta (5Y) 9.86
52-Week Price Change -92.81%
50-Day Moving Average 0.00
200-Day Moving Average 0.00
Relative Strength Index (RSI) 43.76
Average Volume (20 Days) 32,147

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.00

Income Statement

In the last 12 months, GB Sciences had revenue of 97,235 and -1.06 million in losses. Loss per share was -0.00.

Revenue97,235
Gross Profit 97,235
Operating Income -848,406
Pretax Income -1.04M
Net Income -1.06M
EBITDA -847,938
EBIT -848,406
Loss Per Share -0.00
Full Income Statement

Balance Sheet

The company has 3,016 in cash and 1.99 million in debt, giving a net cash position of -1.99 million or -0.00 per share.

Cash & Cash Equivalents 3,016
Total Debt 1.99M
Net Cash -1.99M
Net Cash Per Share -0.00
Equity (Book Value) -5.88M
Book Value Per Share -0.01
Working Capital -5.32M
Full Balance Sheet

Cash Flow

Operating Cash Flow -506,443
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -872.53%
Pretax Margin -1,072.60%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GB Sciences does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.24%
Shareholder Yield n/a
Earnings Yield -2,592.93%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

GB Sciences has an Altman Z-Score of -1735.7 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1735.7
Piotroski F-Score 1